Synlogic Reports Q4 Results, Shares Down 3%
Synlogic, Inc. (NASDAQ:SYBX) shares were trading 3% lower Friday afternoon following the company’s Q4 results.
The company has several clinical updates on deck for 2022— starting with initial results for SYNB1934 in PKU in the first half of the year—which is expected to inform a product candidate selection for a planned pivotal trial in the second half of the year.
With shares trading near cash, analysts at Oppenheimer see an attractive buying opportunity ahead of upcoming readouts.
| Symbol | Price | %chg |
|---|---|---|
| 207940.KS | 1020000 | -0.39 |
| 068270.KS | 180700 | -2.1 |
| 196170.KQ | 303500 | -1.32 |
| 091990.KQ | 75900 | 0 |
SYBX Ratings Summary
SYBX Quant Ranking
Related Analysis
